Image-Guided Therapy Systems Market Report 2026

Image-Guided Therapy Systems Market Overview

• Image-Guided Therapy Systems market size has reached to $5.13 billion in 2025 • Expected to grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.2% • Growth Driver: Growing Demand For Minimally Invasive Surgeries Driving The Market Growth Due To Increasing Need For Real-Time Imaging And Precision • Market Trend: Integration Of Low-Dose Imaging And Neuro Suite Software In Modern Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Image-Guided Therapy Systems Market?

Image-guided therapy systems are advanced medical technologies that use real-time imaging to guide and monitor the delivery of therapeutic procedures. These systems help physicians to precisely locate, target, and treat specific areas within the body, improving accuracy and minimizing damage to surrounding healthy tissues. They enhance treatment outcomes and reduce complications. The main product types of image-guided therapy systems include ultrasound systems, endoscopes, magnetic resonance imaging (MRI), X-ray fluoroscopy or C-arms, positron emission tomography (PET), single-photon emission computed tomography (SPECT), and other product types. Ultrasound systems are imaging devices that use high-frequency sound waves to produce real-time, radiation-free visuals of internal organs and guide minimally invasive procedures. These systems use various technologies such as electromagnetic navigation, robotic-assisted imaging guidance, artificial intelligence (AI)-enhanced real-time 3D or 4D imaging, augmented or mixed-reality visualization, and optical and laser-based tracking. Based on modality portability, they are categorized into fixed systems, mobile C-arms, and hand-held or portable systems. These systems are used for various applications, including cardiac surgery, neurosurgery, orthopedic surgery, gastroenterology, urology, oncology, ear, nose, and throat (ENT) surgery, and others. They are utilized by various end users such as hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutions.

What Is The Image-Guided Therapy Systems Market Growth Forecast?

The image-guided therapy systems market size is expected to see strong growth in the next few years. It will grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to growth in telemedicine adoption, integration with AI-driven analytics, rising geriatric population, expansion of homecare infrastructure, increasing consumer preference for personalized health monitoring. Major trends in the forecast period include remote sleep monitoring, personalized sleep health insights, integration with wearable health devices, data-driven sleep disorder diagnosis, home-based patient care adoption.

Global Image-Guided Therapy Systems Market Segmentation

1) By Product Type: Ultrasound Systems, Endoscopes, Magnetic Resonance Imaging (MRI), X-Ray Fluoroscopy Or C-Arms, Positron Emission Tomography (PET), Single-Photon Emission CT (SPECT), Other Product Types 2) By Technology: Electromagnetic Navigation, Robotic-Assisted Imaging Guidance, Artificial Intelligence (AI)-Enhanced Real-Time 3D Or 4D Imaging, Augmented Or Mixed-Reality Visualization, Optical And Laser-Based Tracking 3) By Modality Portability: Fixed Systems, Mobile C-Arms, Hand-Held Or Portable 4) By Application: Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Gastroenterology, Urology, Oncology, Ear, Nose, And Throat Surgery, Other Applications 5) By End Use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions Subsegments: 1) By Ultrasound Systems: Two-Dimensional (2D) Ultrasound Systems, Three-Dimensional (3D) And Four-Dimensional (4D) Ultrasound Systems, Doppler Ultrasound Systems, Contrast-Enhanced Ultrasound Systems, Portable and Handheld Ultrasound Devices 2) By Endoscopes: Rigid Endoscope Systems, Flexible Endoscope Systems, Image-Guided Therapeutic Endoscope Systems, Robot-Assisted Endoscopic Systems, Single-Use (Disposable) Endoscope Systems 3) By Magnetic Resonance Imaging (MRI): Open Magnetic Resonance Imaging Systems, Closed Magnetic Resonance Imaging Systems, Interventional MRI Systems, 1.5 Tesla Magnetic Resonance Imaging Systems, 3 Tesla Magnetic Resonance Imaging Systems, Intraoperative Magnetic Resonance Imaging (iMRI) Systems 4) By X-Ray Fluoroscopy or C-Arms: Mobile C-Arm Imaging Systems, Mini C-Arm Imaging Systems, Fixed C-Arm Imaging Systems, Flat Panel Detector C-Arm Systems, Image Intensifier C-Arm Systems 5) By Positron Emission Tomography (PET): Positron Emission Tomography–Computed Tomography (PET-CT) Systems, Positron Emission Tomography–Magnetic Resonance Imaging (PET-MRI) Systems, Time-Of-Flight (TOF) Positron Emission Tomography Systems, Digital Positron Emission Tomography Systems 6) By Single-Photon Emission Computed Tomography (SPECT): Standalone Single-Photon Emission Computed Tomography Systems, Hybrid Single-Photon Emission Computed Tomography Or Computed Tomography Systems, Multi-Head Single-Photon Emission Computed Tomography Systems, Cardiac Single-Photon Emission Computed Tomography Systems 7) By Other Product Types: Computed Tomography (CT) Imaging Systems, Optical Imaging Systems, Photoacoustic Imaging Systems, Hybrid Operating Room Systems, Gamma Camera Imaging Systems

What Is The Driver Of The Image-Guided Therapy Systems Market?

The growing demand for minimally invasive surgeries is expected to propel the growth of the image-guided therapy systems market going forward. Minimally invasive surgeries involve surgical techniques that limit the size and number of incisions, reducing patient trauma and recovery time. The rising demand for minimally invasive surgeries is primarily due to their benefits of reduced recovery time, as these procedures typically involve smaller incisions, causing less tissue damage and enabling patients to return to normal activities more quickly compared to traditional open surgeries. Image-guided therapy systems support minimally invasive surgeries by offering real-time imaging that allows surgeons to accurately navigate instruments and target treatment areas while preserving surrounding healthy tissue. For instance, in February 2024, according to the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, in 2023, minimally invasive procedures comprised 83% of all medical procedures performed, whereas traditional surgical procedures accounted for the remaining 17%. Therefore, the growing demand for minimally invasive surgeries is driving the growth of the image-guided therapy systems industry.

Key Players In The Global Image-Guided Therapy Systems Market

Major companies operating in the image-guided therapy systems market are Medtronic plc, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Olympus Corporation, Smith & Nephew plc, Hologic Inc., Shimadzu Corporation, KARL STORZ SE & Co. KG, Cook Medical LLC, Elekta AB, Leica Microsystems GmbH, Brainlab AG, Analogic Corporation, Hyperfine Inc., Quest Medical Imaging B.V.

Global Image-Guided Therapy Systems Market Trends and Insights

Major companies operating in the image-guided therapy systems market are focusing on developing innovative solutions, such as 3D imaging solutions, to enhance diagnostic accuracy, improve procedural efficiency, and enable precise, minimally invasive interventions for better patient outcomes. 3D imaging solutions are advanced medical imaging technologies that create three-dimensional visual representations of internal body structures, enabling healthcare professionals to view anatomy with greater depth and detail. For instance, in February 2024, Koninklijke Philips N.V., a Netherlands-based healthcare technology company, launched its new Azurion neuro biplane image-guided therapy system at the European Congress of Radiology (ECR) 2024. The system features enhanced 2D and 3D imaging, automated beam rotation for image orientation, advanced C-arm angulation and rotation, and comprehensive table-side control to maintain a sterile environment. It also includes a head immobilizer for improved stroke care and supports flexible X-ray detector positioning. Integrated with Philips’ ClarityIQ low-dose imaging technology and neuro suite software, this launch underscores Philips’ commitment to enabling efficient workflows, improving clinical decision-making, and advancing patient outcomes in neurovascular procedures.

What Are Latest Mergers And Acquisitions In The Image-Guided Therapy Systems Market?

In October 2023, GE HealthCare Technologies Inc., a US-based medical technology company, partnered with Boston Scientific Corporation to integrate the AVVIGO+ Multi-Modality Guidance System with its Allia IGS Pulse platform to streamline interventional cardiology workflows. With this partnership, GE HealthCare and Boston Scientific aim to enable interventional cardiologists to control multiple third-party devices from a single interface, enhance multimodality guidance, and improve procedural efficiency. Boston Scientific Corporation is a US-based medical device company that specializes in providing interventional cardiovascular solutions.

Regional Outlook

North America was the largest region in the image-guided therapy systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Image-Guided Therapy Systems Market?

The image-guided therapy systems market consists of revenues earned by entities by providing services such as real-time imaging and navigation support, treatment planning and simulation, intraoperative imaging integration, system installation and maintenance, training and education services. The market value includes the value of related goods sold by the service provider or included within the service offering. The image-guided therapy systems market also includes sales of image-guided surgical navigation systems, robotic-assisted surgical systems, laser-based imaging systems, optical coherence tomography (OCT) systems, intraoperative imaging systems, and gamma cameras, infrared imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.